Cresco Labs Inc.
CRLBF evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for CRLBF—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$300.1M
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Dec 31, 2025.
Run Cresco Labs Inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Cresco Labs Inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 2.78
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
8
Total value held
$249K
| Holder | Shares | Value |
|---|---|---|
| first national trust co | 113,837 | $99K |
| albert d mason inc | 88,035 | $77K |
| ancora advisors llc | 60,169 | $53K |
| curio wealth, llc | 20,161 | $18K |
| strategic investment solutions, inc. /il | 1,408 | $1K |
| hurley capital, llc | 1,014 | $882 |
| thompson investment management, inc. | 725 | $631 |
| hantz financial services, inc. | 9,020 | $8 |
Frequently asked questions
Who is the CEO of Cresco Labs Inc.?
Mr. Charles Bachtell is the chief executive officer of Cresco Labs Inc. (CRLBF).
Where is Cresco Labs Inc. headquartered?
Cresco Labs Inc. (CRLBF) is headquartered in Chicago, IL, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.